Pacific Biosciences Of California reported $39.25M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Accelerate Diagnostics AXDX:US 10.67M 819K
Agilent A:US $ 386M 31M
Bruker BRKR:US $ 152.2M 6.1M
Danaher DHR:US $ 2.08B 7M
Fluidigm FLDM:US $ 30.38M 491K
General Electric GE:US $ 2.7B 92M
Illumina ILMN:US $ 308M 118M
Nanostring Technologies NSTG:US $ 36.11M 243K
Pacific Biosciences Of California PACB:US $ 39.25M 552K
Perkinelmer PKI:US $ 330.02M 16.13M
Thermo Fisher Scientific TMO:US $ 1.74B 537M
Waters WAT:US $ 161.88M 4.4M